Insight on the Evolving Management of High-Risk Resectable Melanoma

Download this slideset to gain key insights on adjuvant therapy and best practice management of high-risk melanoma through the use of targeted therapy and immunotherapy
Ahmad Tarhini, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.09 MB
Released: November 3, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Novartis Pharmaceuticals Corporation

Related Content

Concise interactive module featuring expert insights on empowering melanoma patients to participate in their own care

Trish Brothers, BSN Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 2, 2021 Expired: March 1, 2022

Expert commentary from Allison Betof Warner, MD, PhD, on selecting optimal frontline therapy for metastatic melanoma, from Clinical Care Options (CCO)

person default Allison Betof Warner, MD, PhD Released: February 17, 2021

Gain key clinical insights fast, with this short slideset from CCO on therapy for high-risk, resectable melanoma and metastatic melanoma.

Michael A. Davies, MD, PhD Ahmad Tarhini, MD, PhD Released: November 6, 2020

In this slideset from Clinical Care Options (CCO), Michael Davies, MD, PhD offers insight on optimizing therapeutic strategies for advanced melanoma

Michael A. Davies, MD, PhD Released: November 3, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue